Clinical Trial Update: HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating hepatic arterial infusion irinotecan with intravenous bevacizumab, and combinations of bevacizumab with oxaliplatin or cetuximab, in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Camptosar (irinotecan)
• ERBITUX (cetuximab)
• Eloxatin (oxaliplatin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Liver Cancer, Advanced Cancer | Phase 1 | Status: COMPLETED